The Next Industrial Revolution
After decades of offshoring and capital erosion, US industrial investment is entering a new cycle. Capital is flowing back into manufacturing, materials, infrastructure, heavy industry and technology, driven by reshoring, policy support and supply chain realignment. For investors, this shift…
Q1 2026 Credit Market Update
In this installment of the Portage Point Credit Market Update, the Capital Advisory team summarizes Q1 2026 market activity, benchmarks results against prior periods, comments on key credit market developments and offers insights into the outlook for the remainder of…
Mark Johnson Discusses Market Impact of Energy Price Volatility in PE Hub
Mark Johnson, Head of Industrials Investment Banking, recently discussed how energy price volatility is impacting industrials M&A with PE Hub. “What’s happening now are new forces in play,” Portage Point’s Johnson said about macro geopolitical factors happening in real time….
Combined Six Regional Automotive Aftermarket Distributors into a Leading National Platform
SITUATION OVERVIEW MOC Products is a leading manufacturer, distributor and supplier of performance fluids and maintenance, repair and operations solutions for the automotive aftermarket. The Company previously operated as six distinct businesses – one manufacturer and five regional distributors. The…
Omni Agent Solutions Acquired by Fortress Investment Group
Portage Point is pleased to announce that Omni Agent Solutions Inc. (Omni) has been acquired by funds managed by affiliates of Fortress Investment Group (Fortress). Portage Point acted as exclusive sell-side financial advisor to Omni. Founded in 1970, Omni provides…
LKCM Headwater Completes the Acquisition, Merger and Consolidation of MOC Products and its Related Entities
Portage Point is pleased to announce that LKCM Headwater Investments (LKCM) has completed the acquisition, recapitalization, merger and consolidation of MOC Products and its affiliates into a unified national platform. Portage Point served as exclusive buy-side M&A advisor and exclusive placement agent, supporting transaction execution, executing…
Executed a Value Maximizing Sale Process for a Public Biotechnology Company
SITUATION OVERVIEW Omega Therapeutics, a public biotechnology company focused on developing programmable epigenomic mRNA medicines, operated in a capital-intensive sector requiring sustained investment in research and clinical development. Due to significant research and development (R&D) costs, the Company faced increasing…
